MedPath

The effect mobile application on blood sugar control and lifestyle diabetics

Phase 2
Conditions
Diabetes Mellitus type II.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT2016101630320N1
Lead Sponsor
Vice chancellor for research, Shiraz University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
132
Inclusion Criteria

Diabetes Mellitus Type II and requires daily injections of insulin (based on the detection endocrinologist, citing patient record); The minimum literacy education (the educated are not medical science.); Traverse at least one year of their infection diagnosed diabetes (condition is stabilized); Having the ability to understand content based on investigator judgment; Having to know the Persian languag; Non- pregnant women; Consent to participate in the study; Having a mobile phone with the ability to install applications; The ability to work with Mobile App; Lack of immune deficiency diseases; No underlying chronic disease; Exclusion criteria: Not wanting to continue participating in study; Failure to submit blood sugar for a week; Hospitalization

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Glycosylated hemoglobin. Timepoint: Before intervention, three months after intervention. Method of measurement: Blood test.;Life style. Timepoint: Before intervention, three months after intervention. Method of measurement: Life style Questionnaire.
Secondary Outcome Measures
NameTimeMethod
Body mass index. Timepoint: Before intervention, three months after intervention. Method of measurement: Weight (kg)/ height (m)2.;Blood Pressure. Timepoint: Before intervention, three months after intervention. Method of measurement: Sphygmomanometer.
© Copyright 2025. All Rights Reserved by MedPath